#Adverum Biotechnologies Faces Investor Concerns Amidst Stagnant Performance in Booming Biotech Sector,

#Adverum Biotechnologies Faces Investor Concerns Amidst Stagnant Performance in Booming Biotech Sector,

Adverum Biotechnologies, Inc. Under Investor Scrutiny Amidst Comparatively Stagnant Performance' Pomerantz Law Firm, a highly respected and longstanding authority in securities litigation, has recently announced an investigation on behalf of investors in Adverum Biotechnologies, Inc. This investigation serves to delve into potential claims concerning the company, particularly centered on investor grievances. Interested parties are encouraged to …

New fund will pressure flailing biotechs, as investor frustration boils over

The horde of zombie biotechs lurching ahead and barely surviving has reached a crisis level for some investors. Now there’s a new investment fund targeting these companies. Nicholas Johnston, a longtime healthcare banker at JP ...